1. Home
  2. PLSE vs OPK Comparison

PLSE vs OPK Comparison

Compare PLSE & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLSE
  • OPK
  • Stock Information
  • Founded
  • PLSE 2014
  • OPK 2007
  • Country
  • PLSE United States
  • OPK United States
  • Employees
  • PLSE N/A
  • OPK N/A
  • Industry
  • PLSE Medical/Dental Instruments
  • OPK Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLSE Health Care
  • OPK Health Care
  • Exchange
  • PLSE Nasdaq
  • OPK Nasdaq
  • Market Cap
  • PLSE 1.0B
  • OPK 1.0B
  • IPO Year
  • PLSE 2016
  • OPK 1995
  • Fundamental
  • Price
  • PLSE $17.98
  • OPK $1.45
  • Analyst Decision
  • PLSE
  • OPK Strong Buy
  • Analyst Count
  • PLSE 0
  • OPK 3
  • Target Price
  • PLSE N/A
  • OPK $2.75
  • AVG Volume (30 Days)
  • PLSE 136.2K
  • OPK 3.0M
  • Earning Date
  • PLSE 10-30-2024
  • OPK 11-07-2024
  • Dividend Yield
  • PLSE N/A
  • OPK N/A
  • EPS Growth
  • PLSE N/A
  • OPK N/A
  • EPS
  • PLSE N/A
  • OPK N/A
  • Revenue
  • PLSE N/A
  • OPK $716,372,000.00
  • Revenue This Year
  • PLSE N/A
  • OPK N/A
  • Revenue Next Year
  • PLSE N/A
  • OPK $1.36
  • P/E Ratio
  • PLSE N/A
  • OPK N/A
  • Revenue Growth
  • PLSE N/A
  • OPK N/A
  • 52 Week Low
  • PLSE $4.57
  • OPK $0.85
  • 52 Week High
  • PLSE $22.69
  • OPK $1.75
  • Technical
  • Relative Strength Index (RSI)
  • PLSE 54.90
  • OPK 45.00
  • Support Level
  • PLSE $14.06
  • OPK $1.42
  • Resistance Level
  • PLSE $18.09
  • OPK $1.50
  • Average True Range (ATR)
  • PLSE 1.35
  • OPK 0.07
  • MACD
  • PLSE 0.07
  • OPK -0.00
  • Stochastic Oscillator
  • PLSE 89.91
  • OPK 32.00

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.

Share on Social Networks: